Latest research by St. George’s University (SGU) may be key to curbing increasing cardiovascular concerns in the Middle East. Faculty members at SGU’s School of Medicine — Dr. Rohit Mishra and Dr. Aishwarya Singh — have recently concluded a study that could significantly impact global heart health and associated treatments.
The research program evaluated the benefits and risks of beta blockers, a class of medications used to manage abnormal heart rhythms and prevent recurrent heart attacks. The findings offer hope to those suffering from heart problems and co-existing conditions, suggesting beta blockers can be an effective treatment option. However, the effectiveness varies based on factors such as medical history and gender.
The research findings were published in a book by the duo titled Beta Blocker: Its Effect and Safety, affirming the safety of beta blockers, especially in patients with hypertension, diabetes, anxiety, and other illnesses. According to the Journal of Current Problems in Cardiology, while the burden of cardiovascular disease has decreased in the region, there remains a considerable death and morbidity rate, particularly from ischemic heart disease.
“The research, subsequently published in our book, helps give patients and doctors an idea of the medicine’s efficacy and benefits. I was diagnosed with hypertension at an early age and took beta blockers. That has inspired my journey into educating the public about this treatment option and its effectiveness on different age groups and genders. However, patients should never use beta blockers without the supervision of a physician,” said Dr. Rohit Mishra, Assistant Professor of Pathology at St. George’s University, School of Medicine.
These findings are expected to educate the public and healthcare professionals on the effectiveness of different beta blockers in treating heart diseases across various demographics.
